Short Interest in Cosmos Health Inc. (NASDAQ:COSM) Increases By 40.6%

Cosmos Health Inc. (NASDAQ:COSM) was the target of a significant increase in short interest in February. As of February 28th, there was short interest totalling 804,000 shares, an increase of 40.6% from the February 13th total of 571,900 shares. Based on an average trading volume of 412,700 shares, the days-to-cover ratio is currently 1.9 days. Approximately 4.9% of the company’s stock are sold short.

Cosmos Health Trading Up 4.1 %

Cosmos Health stock opened at $0.50 on Tuesday. The company has a quick ratio of 1.24, a current ratio of 1.44 and a debt-to-equity ratio of 0.08. Cosmos Health has a 52 week low of $0.44 and a 52 week high of $1.58. The company has a market capitalization of $11.72 million, a price-to-earnings ratio of -0.21 and a beta of 5.60. The stock has a 50-day moving average price of $0.65 and a 200 day moving average price of $0.75.

Insiders Place Their Bets

In other Cosmos Health news, CFO Georgios Terzis purchased 85,778 shares of the stock in a transaction on Friday, December 20th. The stock was acquired at an average price of $0.58 per share, with a total value of $49,751.24. Following the completion of the acquisition, the chief financial officer now owns 727,263 shares in the company, valued at $421,812.54. The trade was a 13.37 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Grigorios Siokas purchased 163,666 shares of the stock in a transaction on Monday, January 13th. The stock was acquired at an average cost of $0.61 per share, with a total value of $99,836.26. Following the acquisition, the chief executive officer now owns 3,937,980 shares of the company’s stock, valued at approximately $2,402,167.80. This represents a 4.34 % increase in their position. The disclosure for this purchase can be found here. Over the last 90 days, insiders acquired 1,175,618 shares of company stock valued at $701,169. 15.61% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Cosmos Health

A hedge fund recently raised its stake in Cosmos Health stock. Geode Capital Management LLC increased its position in shares of Cosmos Health Inc. (NASDAQ:COSM) by 29.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 193,432 shares of the company’s stock after purchasing an additional 43,704 shares during the quarter. Geode Capital Management LLC owned 0.83% of Cosmos Health worth $129,000 as of its most recent SEC filing. 12.61% of the stock is currently owned by institutional investors and hedge funds.

About Cosmos Health

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.